
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+4
LiberaBio is a preclinical stage biotech that develops new oncology treatments based on the proprietary MPN technology. This nanotechnology actively targets tumor and metastatic cells and delivers small and large molecules to on-surface or intracellular targets. The company is creating new treatments by delivering novel antibodies targeting intracellular oncoproteins
Oncology,nanomedicine,drug delivery,antibodies,biosimilars,active targeting,intracellular,oncoproteins,and cytotoxics
Liberabio operates in the Biotechnology research industry.
Liberabio's revenue is 11m - 100m
Liberabio has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.